Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
- PMID: 32955678
- PMCID: PMC7502804
- DOI: 10.1007/s11739-020-02457-2
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
Conflict of interest statement
KF reports no competing interests for the past 36 months. For the past 60 months, one study was funded by the non-profit association Tennessee Smoke-Free Association. AB reports no conflict of interest. RN receives funding from the Food and Drug Administration Center for Tobacco Products via contractual mechanisms with Westat and the National Institutes of Health. Within the past three years, he has served as a paid consultant to the Government of Canada and the FDA via contracts with Industrial Economics Inc., and has received an honorarium for a virtual meeting from Pfizer Inc.
Comment on
-
Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?Intern Emerg Med. 2020 Nov;15(8):1601-1603. doi: 10.1007/s11739-020-02473-2. Epub 2020 Aug 16. Intern Emerg Med. 2020. PMID: 32803630 Free PMC article. No abstract available.
References
-
- Norden MJ, Avery DH, Norden JG, Haynor DR. National smoking rates correlate inversely with COVID-19 mortality. medRxiv. 2020 doi: 10.1101/2020.06.12.20129825. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
